983-P: Effect and Safety of Flexible Dose Adjustment With Oral Semaglutide vs. Sitagliptin in Type 2 Diabetes: PIONEER 7
Diabetes - United States
doi 10.2337/db19-983-p
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
American Diabetes Association